WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

COVID-19 Resource Offers Among Rent and Utility Assistance Applicants in St. Louis

Not Applicable

Completed

Conditions: Behavior and Behavior Mechanisms
Communication

Interventions: Other: Foot-In-The-Door Technique
Other: Door-In-The-Face Technique

First Posted Date: 2022-07-11

Last Posted Date: 2022-11-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 531

Registration Number: NCT05451511

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Behavioral Plant-Based Dietary Intervention in Latinos

Not Applicable

Not yet recruiting

Conditions: Obesity
Metabolic Disease

Interventions: Behavioral: Standard care
Behavioral: Behavioral plant-based dietary intervention

First Posted Date: 2022-07-06

Last Posted Date: 2024-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT05444595

Locations: 🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States

Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

Phase 1

Completed

Conditions: Parosmia
Hyposmia
Anosmia
Olfactory Disorder

Interventions: Drug: Stellate Ganglion Block

First Posted Date: 2022-07-06

Last Posted Date: 2023-11-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT05445921

Locations: 🇺🇸
Washington University School of Medicine/Barnes Jewish Hospital, Saint Louis, Missouri, United States

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS

Not Applicable

Recruiting

Conditions: Myelodysplastic Syndromes
Whole Genome Sequencing

Interventions: Device: ChromoSeq

First Posted Date: 2022-06-28

Last Posted Date: 2024-11-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT05434598

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cannabis, HIV and Mental Processing Systems

Recruiting

Conditions: Cannabis
HIV Infections

Interventions: Procedure: MRI
Other: NeuroPsychological Testing
Procedure: Blood Draw
Other: Questionnaires
Procedure: Lumbar Puncture

First Posted Date: 2022-06-24

Last Posted Date: 2023-12-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 320

Registration Number: NCT05430490

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania, United States

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Not Applicable

Completed

Conditions: Colon Cancer
Brain Cancer
Ovarian Cancer
Head and Neck Cancer
Lung Cancer
Gastric Cancer

Interventions: Device: Halcyon 4.0 system

First Posted Date: 2022-06-22

Last Posted Date: 2024-10-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 55

Registration Number: NCT05427214

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

COVID-19 Vaccine Uptake Trial

Not Applicable

Completed

Conditions: COVID-19
Vaccination Refusal

Interventions: Other: Short Message Service (SMS) + Website Link Strategy
Other: Phone Call with Peer Strategy

First Posted Date: 2022-06-15

Last Posted Date: 2024-12-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6100

Registration Number: NCT05419232

Locations: 🇺🇸
Ferguson-Florissant School District, Hazelwood, Missouri, United States
🇺🇸
Jennings School District, Jennings, Missouri, United States
🇺🇸
St. Louis Language Immersion School, Saint Louis, Missouri, United States

and more 5 locations

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

Phase 1

Recruiting

Conditions: Transformed Lymphoma
Aggressive Lymphoma
B Cell Lymphoma
Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
Follicular Lymphoma Grade 3

Interventions: Drug: Mosunetuzumab

First Posted Date: 2022-06-09

Last Posted Date: 2024-11-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT05412290

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Mosunetuzumab and Polatuzumab Vedotin for Untreated Follicular Lymphoma

Phase 2

Recruiting

Conditions: Lymphoma, Follicular
Follicular Lymphoma

Interventions: Drug: Mosunetuzumab
Drug: Polatuzumab vedotin

First Posted Date: 2022-06-08

Last Posted Date: 2024-01-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT05410418

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia

Not Applicable

Terminated

Conditions: Acute Lymphoblastic Leukemia

Interventions: Behavioral: Family-based Behavioral Weight Loss Treatment

First Posted Date: 2022-06-08

Last Posted Date: 2024-05-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17

Registration Number: NCT05410574

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy